01/09/2015 10:11:12 Free Membership Login

Xoma News (NASDAQ:XOMA)

DateTimeSource
Headline
08/20/20159:11AMPRNUSLaw Offices of Marc S. Henzel Announces Securities Class Action Periods
Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire MERION, Pa., Aug. 20, 2015 MERION, Pa., Aug. 20, 2015 /PRNewswire/ -- The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following... More...>>
08/18/201510:30AMBWTRADING ALERT: The Rosen Law Firm Reminds Xoma Corporation Investors of Important Deadline in Class Action – XOMA
The Rosen Law Firm, a global investor rights firm, reminds purchasers of Xoma Corporation (NASDAQ:XOMA) securities during the period from November 6, 2014 through July 21, 2015 of the important September 22, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Xoma Corporation investors... More...>>
08/03/20155:59PMPRNUSRobbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According to a Recently Filed Class Action
Robbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According to a Recently Filed Class Action PR Newswire SAN DIEGO and BERKELEY, Calif., Aug. 3, 2015 SAN DIEGO and BERKELEY, Calif., Aug. 3, 2015 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that a securities fraud class action... More...>>
07/30/20152:32PMPRNUSSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corpo...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corporation PR Newswire WILMINGTON, Del., July 30, 2015 WILMINGTON, Del., July 30, 2015 /PRNewswire/ -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of XOMA Corporation (NASDAQ GM: XOMA)?... More...>>
07/30/201511:14AMBWEQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Xoma Corporation
The Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of Xoma Corporation (NASDAQ:XOMA) securities during the period from November 6, 2014 through July 21, 2015. The lawsuit seeks to recover damages for Xoma Corporation investors under the federal... More...>>
07/23/201512:20PMBWXOMA SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fr...
Levi & Korsinsky announces it has commenced an investigation of Xoma Corporation (NASDAQ: XOMA) concerning possible violations of federal securities laws. The investigation concerns whether Xoma Corporation and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange... More...>>
07/23/20159:50AMPRNUSOrphan Drug Designation Granted to XOMA 358 - Report on XOMA
Orphan Drug Designation Granted to XOMA 358 - Report on XOMA PR Newswire NEW YORK, July 23, 2015 NEW YORK, July 23, 2015 /PRNewswire/ -- ACI Association has initiated research coverage on XOMA Corporation (NASDAQ: XOMA). Select highlights from the internally released reports are being made available to the general public... More...>>
07/22/20158:36PMBWIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Xoma Corporation on Behalf of Investors
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Xoma Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors... More...>>
07/22/201512:55PMPRNUSSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of XOMA Corporation.
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of XOMA Corporation. PR Newswire NEW YORK, July 22, 2015 NEW YORK, July 22, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of... More...>>
07/22/201510:10AMDJNXoma Shares Plunge on Failed Late-Stage Study
Shares in Xoma Corp. erased most of their value Wednesday after the company said its eye drug failed in a late-stage study. In premarket trading, shares plunged 81% to 85 cents. Xoma developed the drug, gevokizumab, to treat patients with Behç et's disease uveitis, which can lead to permanent vision loss. According... More...>>
07/22/20159:22AMPRNUSBiotechnology Sector Stocks Technical Coverage -- Amgen, Exelixis, XOMA Corp., Theravance, and NewLink Genetics
Biotechnology Sector Stocks Technical Coverage -- Amgen, Exelixis, XOMA Corp., Theravance, and NewLink Genetics PR Newswire NEW YORK, July 22, 2015 NEW YORK, July 22, 2015 /PRNewswire/ -- Equity Research Institute has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Exelixis Inc. (NASDAQ: EXEL... More...>>
07/16/20159:01AMTMF3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
http://www.fool.com/investing/high-growth/2015/07/16/3-biotech-stocks-50-or-more-off-their-5-year-highs.aspx?source=eptadnlnk0000002 More...>>
05/28/20153:11PMTMFWhy XOMA Corp. Shares Rocketed Higher
http://www.fool.com/investing/general/2015/05/28/why-xoma-corp-shares-rocketed-higher.aspx?source=eptadnlnk0000002 More...>>
05/08/20153:22PMTMFHow 1 Sentence Caused XOMA Corp. Shares to Explode Higher
http://www.fool.com/investing/general/2015/05/08/how-1-sentence-caused-xoma-corp-shares-to-explode.aspx?source=eptadnlnk0000002 More...>>
05/07/20154:01PMGLOBEXOMA Reports First Quarter 2015 Achievements and Financial Results
BERKELEY, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and financial results for the first quarter ended March 31, 2015. "During the first quarter of this year, we made significant progress... More...>>
05/05/20155:21PMARNXOMA Corp's "Hold" Rating Reiterated at Credit Suisse (XOMA)
http://www.tickerreport.com/banking-finance/500946/xoma-corps-hold-rating-reiterated-at-credit-suisse-xoma/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
05/04/20154:31PMGLOBEXOMA to Present at Credit Suisse Antibody Day 2015
BERKELEY, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Paul Rubin, the Company's Senior Vice President, Research and Development, and Chief Medical Officer, is scheduled to present at the Credit Suisse Antibody... More...>>
04/30/20151:00PMGLOBEXOMA to Announce First Quarter 2015 Financial Results and Host Conference Call on May 7
BERKELEY, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call on Thursday, May 7, 2015, at 4:30 p.m. Eastern time to discuss first quarter 2015 financial results and provide an update... More...>>
04/01/20158:01AMGLOBEServier Initiates Phase 2 Study of Gevokizumab in Patients With Diabetic Nephropathy
BERKELEY, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today gevokizumab will be tested in a Phase 2 study in patients with Type 2 diabetes and diabetic kidney disease, clinically referred to as diabetic nephropathy... More...>>
03/26/20159:01AMTMF3 Things You Need to Know About XOMA Corp.
http://www.fool.com/investing/general/2015/03/26/3-things-you-need-to-know-about-xoma-corp.aspx?source=eptadnlnk0000002 More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq xoma150901 10:11